创始人简报
根据产品组合信号自动生成每日、每周和每月经营简报。
16
7
5
4
最新 每日
2026-11-02 · claude-4.5-sonnet · 2 min read
MRR 433k — watch Code Review AI AI cost structure
Northwind Labs closed yesterday with portfolio MRR at $432,832 (+6.6% MoM). AI spend is $50,278/mo (11.6% of revenue). Resume AI remains the weakest health signal (77/100) with 3 open incidents across the fleet.
Highlights
- +Live products: 10/12
- +DAU 19,289 · MAU 116,245
- +Gross margin 83.1%
- +310 deploys in the last 30 days
Concerns
- !Code Review AI AI cost ratio 28.7%
- !Resume AI health 77/100
- !Blended churn 3.51%
MRR
$433k
+6.6%
AI Cost
$50k
+18.4%
DAU
19,289
+4.2%
Uptime
99.81%
+0.1%
Health
84
-1.2%
Incidents
3
+40.0%
Archive
All generated briefs
MRR 433k — watch Code Review AI AI cost structure
Northwind Labs closed yesterday with portfolio MRR at $432,832 (+6.6% MoM). AI spend is $50,278/mo (11.6% of revenue). Resume AI remains the weakest health signal (77/100) with 3 open incidents across the fleet.
Cost watch: AI line rose faster than revenue
Northwind Labs closed yesterday with portfolio MRR at $432,832 (+6.6% MoM). AI spend is $50,278/mo (11.6% of revenue). Resume AI remains the weakest health signal (77/100) with 3 open incidents across the fleet.
Quiet ops day — growth held at 6.6%
Northwind Labs closed yesterday with portfolio MRR at $432,832 (+6.6% MoM). AI spend is $50,278/mo (11.6% of revenue). Resume AI remains the weakest health signal (77/100) with 3 open incidents across the fleet.
Cost watch: AI line rose faster than revenue
Northwind Labs closed yesterday with portfolio MRR at $432,832 (+6.6% MoM). AI spend is $50,278/mo (11.6% of revenue). Resume AI remains the weakest health signal (77/100) with 3 open incidents across the fleet.
Quiet ops day — growth held at 6.6%
Northwind Labs closed yesterday with portfolio MRR at $432,832 (+6.6% MoM). AI spend is $50,278/mo (11.6% of revenue). Resume AI remains the weakest health signal (77/100) with 3 open incidents across the fleet.
Cost watch: AI line rose faster than revenue
Northwind Labs closed yesterday with portfolio MRR at $432,832 (+6.6% MoM). AI spend is $50,278/mo (11.6% of revenue). Resume AI remains the weakest health signal (77/100) with 3 open incidents across the fleet.
Quiet ops day — growth held at 6.6%
Northwind Labs closed yesterday with portfolio MRR at $432,832 (+6.6% MoM). AI spend is $50,278/mo (11.6% of revenue). Resume AI remains the weakest health signal (77/100) with 3 open incidents across the fleet.
Week in review — ARR path to $5.5M
Across the week, Northwind Labs compounded MRR while AI cost efficiency diverged by product. Analytics Copilot led growth; Resume AI absorbed the most incident time.
Week in review — ARR path to $5.5M
Across the week, Northwind Labs compounded MRR while AI cost efficiency diverged by product. Analytics Copilot led growth; Resume AI absorbed the most incident time.
Week in review — ARR path to $5.5M
Across the week, Northwind Labs compounded MRR while AI cost efficiency diverged by product. Analytics Copilot led growth; Resume AI absorbed the most incident time.
Week in review — ARR path to $5.5M
Across the week, Northwind Labs compounded MRR while AI cost efficiency diverged by product. Analytics Copilot led growth; Resume AI absorbed the most incident time.
Week in review — ARR path to $5.5M
Across the week, Northwind Labs compounded MRR while AI cost efficiency diverged by product. Analytics Copilot led growth; Resume AI absorbed the most incident time.
Monthly board brief — portfolio health 84
Monthly view for investors and the founding team. Revenue, AI COGS, reliability and the top three strategic bets are summarized below with quantified recommendations.
Monthly board brief — portfolio health 84
Monthly view for investors and the founding team. Revenue, AI COGS, reliability and the top three strategic bets are summarized below with quantified recommendations.
Monthly board brief — portfolio health 84
Monthly view for investors and the founding team. Revenue, AI COGS, reliability and the top three strategic bets are summarized below with quantified recommendations.
Monthly board brief — portfolio health 84
Monthly view for investors and the founding team. Revenue, AI COGS, reliability and the top three strategic bets are summarized below with quantified recommendations.